Nitric oxide synthase (NOS) has been proposed to contribute to endothelial dysfunction in HFpEF [105, 106], and NOS1 inhibition was recently associated with recovery of diastolic dysfunction in a murine model resembling HFpEF [128]. This evidence concerns the gene NOS1 and endothelial dysfunction.